Novavax says its COVID-19 shot is on track for full FDA approval after delay
WASHINGTON — Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.
The news sent company shares soaring more than 21% in morning trading and appeared to resolve concerns that Trump administration officials might be holding up a decision on the shot.
Novavax makes the nation's only traditional protein-based COVID-19 vaccine. It is still being sold under emergency use authorization — unlike mRNA vaccines made by Pfizer and Moderna that have earned full FDA approval for certain age groups.
The FDA recently asked Novavax to develop a plan for collecting additional clinical data from those who have gotten the shot, the company said in a statement. It said it is 'engaging with the FDA expeditiously' in hopes of receiving approval 'as soon as possible.'
At FDA, full vaccine approval is the gold standard. The agency was on track to sign off on Novavax's license by its April 1 target date, according to two people with direct knowledge of the situation who spoke on condition of anonymity to discuss confidential agency matters.
But FDA's acting commissioner, Dr. Sara Brenner, directed the agency's lead official overseeing the vaccine to pause the decision, according to one of the people. The delay, first reported by The Wall Street Journal, sparked concerns of political interference under Robert F. Kennedy Jr., who spent decades leading antivaccine groups before joining the federal government as health secretary.
Last month, FDA's longtime vaccine chief, Dr. Peter Marks, was forced out over disagreements with Kennedy about vaccine safety.
With full FDA approval, Novavax would have permission to keep its shot on the market indefinitely. Products that receive emergency authorization can be removed by FDA after there is no longer a health emergency.
All the COVID-19 vaccines used in the U.S. train the body to fight the coronavirus by recognizing its outer coating, the spike protein.
The Pfizer and Moderna options deliver genetic instructions for the body to temporarily make copies of the protein. In contrast, the Novavax vaccine uses lab-grown copies of the spike protein packaged into nanoparticles and combined with an immune-revving ingredient. Protein-based vaccines have been used for years to prevent other diseases including hepatitis B and shingles.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Local leaders respond to potential Medicaid cuts
DERBY, Conn. (WTNH) — Leaders of multiple local hospitals came together Monday morning to warn what might happen if Republicans in Congress pass their proposed changes to Medicaid. They worry state and local costs will skyrocket if the federal government makes proposed changes to how the program works. One of the proposed changes involves charging low-income patients a co-pay of as much as $35 for certain medical appointments. Hartford HealthCare introduces 'Empowering New Parents' program 'What this does is act as a barrier,' said Griffin Hospital CEO Patrick Charmel. 'People will see they have an out-of-pocket responsibility and just won't pursue the care that they need.' Eventually, he said, those people will end up in the emergency room, which ends up costing more. The Trump administration contends their changes will lower insurance premiums, but Congresswoman Rosa DeLauro (D-CT3) disagrees. 'Premiums for individual plans sold on Access Health CT will increase by as much as 25% next year,' DeLauro said. DeLauro says proposed cuts threaten access to health care for nearly 14 million people nationwide. A white house spokesman had a different take in an emailed statement. 'President Trump pledged to protect and preserve Medicaid, and that's exactly what The One, Big, Beautiful accomplishes by kicking illegal immigrants off the program, implementing commonsense work requirements, and enforcing basic eligibility verification to combat fraud,' wrote spokesman Kush Desai. Hartford HealthCare and Pfizer partner to tackle workplace migraines For those not on Medicaid, they may wonder why they should care about these cuts. Hospitals have to provide care to everybody who needs it, whether they can pay for it or not. If there is less money from the government coming in to pay for low-income patients, that means hospitals that are already stretched thin financially, could find themselves in serious financial trouble. 'Cuts to programs that support our communities like Medicaid will stress that ecosystem further and bring changes, challenges and collapses to some of our critical infrastructure across the state of Connecticut,' said Dr. Tom Balcezak, EVP & Chief Clinical Officer, Yale New Haven Health System. Which, they say, means fewer people seeing fewer doctors. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
19 minutes ago
- Yahoo
Arkansas ranks 45th for child well-being in national report, despite modest gains
LITTLE ROCK, Ark. – Arkansas ranks 45th in the nation for overall child well-being, according to the 2025 KIDS COUNT Data Book released Monday by the Annie E. Casey Foundation. The annual report evaluates how children are doing across all 50 states in four areas: economic well-being, education, health, and family and community. 6-year-old Dennis Martin still missing after disappearing in Smokies in 1969 Though Arkansas has made some gains since the COVID-19 pandemic, the state continues to fall behind on most indicators compared to national averages. One area of progress is child poverty. The number of Arkansas children living in poverty has dropped by 7,000 since 2019. Still, 21% of the state's children remain in poverty, which is higher than the national rate of 16%. 'This report shows that while there has been some improvement, too many of our children are still being left behind,' said Keesa Smith-Brantley, executive director of Arkansas Advocates for Children and Families. 'We can't be satisfied with small gains when the overall trends remain troubling.' Racial disparities remain a serious issue. Officials said Black children in Arkansas face a poverty rate of 43%. Children of two or more races have a poverty rate of 21%, while 19% of Hispanic or Latino children live in poverty. Non-Hispanic White children have the lowest poverty rate at 15%. Ohio girl with brain injury from flu complications returns home In addition to being ranked 44th for child poverty, Arkansas is in the bottom 10 states on the following indicators: Teens ages 16-19 not attending school and not working 8th graders below proficient on math level Low-birthweight babies Child and teen deaths Teens ages 10-17 who are overweight or obese Children in single-parent families Children living in high-poverty areas Teen birth rate 'If you look at the data, teens are where we're falling further behind,' Smith-Brantley said. 'We're seeing more teens out of school and unemployed, and more who are overweight or obese. These are outcomes tied directly to the decisions our leaders are or aren't making.' For more information, visit Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
The Hill
34 minutes ago
- The Hill
Tariffs are raising health care costs and putting patients at risk
Lately, my bi-weekly calls with my 24-year-old daughter, a medical assistant preparing for med school, are starting to sound more like supply chain audits. She tells me which items are running low at her clinic and how the team is scrambling to provide quality care to patients. Having been raised by a parent who managed global supply chains, she knows these aren't just inventory issues — they are cracks in a fragile health care system now under further strain from President Trump's tariffs and the uncertainty surrounding them. Last year alone, the U.S. imported more than $75 billion in medical devices and supplies. While headlines have focused on potentially higher costs for pharmaceuticals and high-tech medical equipment, the more urgent and often overlooked concern is the availability of basic, everyday lifesaving supplies. Gloves, syringes, sterile water, IV fluids and even diapers may seem mundane, but they are the lifeblood of clinical care. Hospitals spend approximately 25 percent of their budget on these high-volume items. Most of these essentials are imported. For example, two-thirds of non-disposable face masks and 94 percent of plastic gloves used in U.S. health care settings come from China. Already impacted by tariffs implemented last year to counter low-cost imports, these products are now becoming even more expensive. Enteral syringes used to deliver medication or nutrition through feeding tubes are now subject to a staggering 245 percent tariff, according to one group purchasing organization. If trade tensions continue to escalate, we could see a return to pandemic-era supply shortages — or worse. As hospitals prepare for these impacts, it's their patients who will bear the repercussions. The American Hospital Association recently reported that 82 percent of health care leaders expect tariff-related price hikes to increase hospital costs by at least 15 percent within six months. One major health system in Washington projected that tariffs could increase annual costs by $10 to $25 million. With Medicaid reimbursement rates set by the government and private insurance reimbursement rates held in place by contracts, hospitals can't easily pass on these increases. Instead, they absorb the costs and find other cuts, like reducing staffing or delaying upgrades. That could mean longer wait times, postponed procedures and ultimately, worse outcomes for patients. Rural hospitals and community providers already operating on razor-thin margins will feel these burdens most acutely. Close to 200 rural hospitals have closed in the past two decades, and nearly 700, or close to one-third of all additional rural hospitals, are at risk of closing in the near future. When policymakers impose sweeping trade measures without fully considering downstream effects, the entire health care system suffers the consequences. The disruption often costs more than the policy itself, in both dollars and diminished patient care. Health care policy is essential for a productive economy, which is the main goal of the president's tariffs. Medical supplies should be exempted from tariffs. This would help to ensure more consistent pricing and ensure Americans have access to the health care essentials they need. Policymakers can also help bring manufacturing for some of these products back home by investing in more public-private partnerships and supporting infrastructure and workforce development to encourage companies to make these goods in the U.S. Finally, the federal and state governments can reengineer the procurement processes for Medicare and Medicaid, and enact measures to ensure more efficient practices in the private sector to enable competition and fair prices. Pharmacy benefit managers and Group Purchasing Organizations need to work on behalf of the patients, hospitals and clinics to better manage costs, similar to processes in other supply chain systems. Overall, policymakers must understand that while tariffs may shift economic leverage, they also shift risk onto patients. My daughter is learning this lesson on the front lines. She went into medicine to deliver care. Lately, and too often, she's just delivering bad news. Jack Buffington is Supply Chain Management Professor at the University of Denver.
